Lanoteplase
拉诺替普酶
Report date: 2023/04/21 17:24:43
Base Information
Drug NameLanoteplase
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesSuntoryPfizer IncBristol-Myers Squibb Company
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A